RJA
DORM icon

Raymond James & Associates’s Dorman Products DORM Stock Holding History

Raymond James & Associates’s Portfolio DORM Stock Details DORM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.94M Buy
34,867
+7,349
+27% +$773K ﹤0.01% 1819
2024
Q2 		$2.52M Sell
27,518
-364
-1% -$33.3K ﹤0.01% 2020
2024
Q1 		$2.69M Sell
27,882
-305
-1% -$26.3K ﹤0.01% 1979
2023
Q4 		$2.35M Sell
28,187
-9,256
-25% -$692K ﹤0.01% 2014
2023
Q3 		$2.84M Sell
37,443
-899
-2% -$73.1K ﹤0.01% 1811
2023
Q2 		$3.02M Sell
38,342
-678
-2% -$57.1K ﹤0.01% 1811
2023
Q1 		$3.37M Sell
39,020
-158
-0.4% -$14.1K ﹤0.01% 1741
2022
Q4 		$3.17M Sell
39,178
-898
-2% -$76.3K ﹤0.01% 1719
2022
Q3 		$3.29M Sell
40,076
-434
-1% -$42.7K ﹤0.01% 1661
2022
Q2 		$4.44M Sell
40,510
-128
-0.3% -$12.7K ﹤0.01% 1473
2022
Q1 		$3.86M Buy
40,638
+356
+0.9% +$34.5K ﹤0.01% 1697
2021
Q4 		$4.55M Sell
40,282
-861
-2% -$93.5K ﹤0.01% 1619
2021
Q3 		$3.9M Sell
41,143
-635
-2% -$62.6K ﹤0.01% 1658
2021
Q2 		$4.33M Sell
41,778
-555
-1% -$56.9K ﹤0.01% 1579
2021
Q1 		$4.34M Sell
42,333
-5,129
-11% -$512K ﹤0.01% 1504
2020
Q4 		$4.12M Sell
47,462
-390
-0.8% -$36.1K ﹤0.01% 1448
2020
Q3 		$4.33M Sell
47,852
-791
-2% -$63.2K 0.01% 1308
2020
Q2 		$3.26M Sell
48,643
-6,086
-11% -$392K ﹤0.01% 1440
2020
Q1 		$3.02M Sell
54,729
-1,065
-2% -$72.5K ﹤0.01% 1330
2019
Q4 		$4.22M Sell
55,794
-3,076
-5% -$233K 0.01% 1359
2019
Q3 		$4.68M Buy
58,870
+34,194
+139% +$2.65M 0.01% 1268
2019
Q2 		$2.15M Sell
24,676
-5,751
-19% -$500K ﹤0.01% 1754
2019
Q1 		$2.68M Buy
30,427
+4,851
+19% +$422K ﹤0.01% 1573
2018
Q4 		$2.3M Sell
25,576
-103
-0.4% -$8.23K ﹤0.01% 1561
2018
Q3 		$1.98M Buy
25,679
+4,860
+23% +$371K ﹤0.01% 1819
2018
Q2 		$1.42M Buy
20,819
+191
+0.9% +$12.9K ﹤0.01% 1983
2018
Q1 		$1.37M Sell
20,628
-4,996
-19% -$356K ﹤0.01% 1927
2017
Q4 		$1.57M Buy
25,624
+2,772
+12% +$188K ﹤0.01% 1848
2017
Q3 		$1.64M Sell
22,852
-9,762
-30% -$702K ﹤0.01% 1774
2017
Q2 		$2.7M Buy
32,614
+22
+0.1% +$1.8K 0.01% 1385
2017
Q1 		$2.68M Buy
32,592
+5,724
+21% +$425K 0.01% 1361
2016
Q4 		$1.96M Sell
26,868
-5,368
-17% -$367K 0.01% 1498
2016
Q3 		$2.06M Buy
32,236
+232
+0.7% +$14.3K 0.01% 1432
2016
Q2 		$1.83M Buy
32,004
+2,249
+8% +$121K 0.01% 1379
2016
Q1 		$1.62M Buy
29,755
+3,801
+15% +$181K 0.01% 1406
2015
Q4 		$1.23M Buy
25,954
+1,047
+4% +$51K ﹤0.01% 1520
2015
Q3 		$1.27M Buy
24,907
+78
+0.3% +$3.91K 0.01% 1470
2015
Q2 		$1.18M Buy
24,829
+7,496
+43% +$365K ﹤0.01% 1639
2015
Q1 		$862K Buy
17,333
+5,223
+43% +$246K ﹤0.01% 1749
2014
Q4 		$585K Sell
12,110
-21,937
-64% -$1.02M ﹤0.01% 1872
2014
Q3 		$1.36M Buy
34,047
+280
+0.8% +$12.5K 0.01% 1316
2014
Q2 		$1.67M Buy
+33,767
New +$1.84M 0.01% 1197

Other funds holding DORM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Raymond James & Associates's DORM Position: Q3 2024 in Review

Raymond James & Associates increased its Dorman Products (DORM) stake by 27% in Q3 2024, buying an estimated $773K and bringing the position to 34,867 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Raymond James & Associates first reported a position in DORM in Q2 2014 and has held it in 42 quarters since. The position peaked at $4.68M in Q3 2019. 303 funds tracked by Wall St. Rank hold DORM as of Q3 2024.

  • Raymond James & Associates held 34,867 shares of Dorman Products worth $3.94M as of Q3 2024.
  • Raymond James & Associates bought 7,349 Dorman Products shares in Q3 2024, an estimated $773K.
  • Dorman Products made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1819 holding.
  • Raymond James & Associates first reported a position in Dorman Products in Q2 2014 and has held it in 42 quarters since.
  • Raymond James & Associates's Dorman Products position peaked at $4.68M in Q3 2019.
  • 303 funds tracked by Wall St. Rank held Dorman Products as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.